BioCardia, Inc. (BCDA) vs Cerenome, Inc. (CNSY)
- BioCardia, Inc. BCDA 0.92 −2.13%
- Cerenome, Inc. CNSY 1.70 −9.57%
BioCardia, Inc. and Cerenome, Inc. are both Biotechnology companies. BioCardia, Inc. and Cerenome, Inc. are of similar size ($14.3M and $14.2M). BioCardia, Inc. grew revenue faster over the last twelve months: 0.71% against −21.0%. BioCardia, Inc. has the higher net margin (0.00% vs −526.5%) and the higher return on invested capital (0.00% vs −532.8%). Across the 16 metrics below, BioCardia, Inc. leads on 10 and Cerenome, Inc. on 6.
Valuation
Profitability
| Metric | BCDA | CNSY | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (628.12%) | 0.00% |
| Net margin | 0.00% | (526.48%) | 0.00% |
| Free cash flow margin | 0.00% | (560.29%) | 0.00% |
| Return on equity | (1,803.19%) | (520.84%) | (56.36%) |
| Return on assets | (214.47%) | (181.53%) | (48.04%) |
| Return on invested capital | 0.00% | (532.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack